Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Adaptimmune Therapeutics PLC | 660,000 | reported | 01 Jul 2024 | tx 6+2,476,515 |
| Spark Therapeutics, Inc. | 6,723 | reported | 20 Apr 2018 | tx 17+252,518−80,018 |
| Vaxcyte, Inc. | 5,306 | reported | 15 Jun 2026 | tx 5+48,827 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Jun 2026 | GRANT_AWARD | Vaxcyte, Inc. | 2,265 | 0.00 USD | |
| 15 Jun 2026 | GRANT_AWARD | Vaxcyte, Inc. | 11,389 | 0.00 USD | deriv |
| 12 Jun 2025 | GRANT_AWARD | Vaxcyte, Inc. | 3,041 | 0.00 USD | |
| 12 Jun 2025 | GRANT_AWARD | Vaxcyte, Inc. | 15,372 | 0.00 USD | deriv |
| 02 Jul 2024 | GRANT_AWARD | Vaxcyte, Inc. | 16,760 | 0.00 USD | deriv |
| 01 Jul 2024 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 660,000 | 0.00 USD | deriv |
| 03 Jul 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 500,000 | 0.00 USD | deriv |
| 01 Jul 2022 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 500,000 | 0.00 USD | deriv |
| 01 Jul 2021 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 379,788 | 0.00 USD | deriv |
| 01 Jul 2020 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 196,186 | 0.00 USD | deriv |
| 02 Jul 2019 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 240,541 | 0.00 USD | deriv |
| 20 Apr 2018 | EXERCISE | Spark Therapeutics, Inc. | 6,723 | 49.74 USD | |
| 20 Apr 2018 | SALE | Spark Therapeutics, Inc. | 6,723 | 82.50 USD | |
| 20 Apr 2018 | EXERCISE | Spark Therapeutics, Inc. | 6,723 | 0.00 USD | deriv |
| 17 Apr 2018 | EXERCISE | Spark Therapeutics, Inc. | 2,277 | 49.74 USD | |
| 17 Apr 2018 | SALE | Spark Therapeutics, Inc. | 2,277 | 82.50 USD | |
| 18 Apr 2018 | EXERCISE | Spark Therapeutics, Inc. | 11,000 | 49.74 USD | |
| 18 Apr 2018 | SALE | Spark Therapeutics, Inc. | 11,000 | 82.53 USD | |
| 17 Apr 2018 | EXERCISE | Spark Therapeutics, Inc. | 2,277 | 0.00 USD | deriv |
| 18 Apr 2018 | EXERCISE | Spark Therapeutics, Inc. | 11,000 | 0.00 USD | deriv |
| 12 Apr 2018 | EXERCISE | Spark Therapeutics, Inc. | 20,000 | 49.74 USD | |
| 12 Apr 2018 | SALE | Spark Therapeutics, Inc. | 20,000 | 77.51 USD | |
| 12 Apr 2018 | EXERCISE | Spark Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 08 Dec 2017 | PURCHASE | Spark Therapeutics, Inc. | 18 | 73.48 USD | |
| 11 Dec 2017 | SALE | Spark Therapeutics, Inc. | 18 | 46.33 USD |